NALMEFENE HYDROCHLORIDE
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $581,909 | 280 | 232 |
| 2023 | $116,451 | 79 | 67 |
| 2022 | $955,380 | 34 | 24 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1.6M | 16 | 97.1% |
| Consulting Fee | $28,816 | 15 | 1.7% |
| Education | $11,439 | 5 | 0.7% |
| Food and Beverage | $7,211 | 356 | 0.4% |
| Honoraria | $330.00 | 1 | 0.0% |
Payments by Type
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| A Two-Part Study to Characterize the Pharmacokinetics of Nalmefene Hydrochloride and to Assess the Time Course of Reversal and Breakthrough of Opioid Agonist Effects Following Naloxone and Nalmefene Administration | Purdue Pharma L.P. | $919,395 | 0 |
| Clinical Outcomes from Injectable Nalmefene in the Emergency Department | Purdue Pharma L.P. | $478,080 | 0 |
| A Pragmatic, Single Arm Trial of Prehospital Nalmefene for Treatment of Opioid Toxicity in a Population with High Fentanyl Use | Purdue Pharma L.P. | $105,475 | 0 |
| Evaluation of Nalmefene HCl Injection for Recurrent Respiratory Depression After Suspected Acute Opi | Purdue Pharma L.P. | $72,995 | 0 |
| Clinical Outcomes from Injectable Nalmefene in the Emergency Department (COINED) | Purdue Pharma L.P. | $30,000 | 0 |
Top Doctors Receiving Payments for NALMEFENE HYDROCHLORIDE
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | Columbus, OH | $1.6M | 18 |
| , MD | Anesthesiology | Greenwood Village, CO | $13,612 | 10 |
| , M.D | Emergency Medicine | San Antonio, TX | $7,462 | 2 |
| , M.D | Specialist | Columbus, OH | $4,615 | 1 |
| , M.D | Pediatrics | Santee, CA | $4,016 | 1 |
| , MD | Anesthesiology | Stanford, CA | $3,835 | 2 |
| , MD | Anesthesiology | Aurora, CO | $3,412 | 2 |
| , MD | Pediatric Anesthesiology | Louisville, KY | $2,869 | 2 |
| , MD | Emergency Medicine | San Francisco, CA | $480.00 | 1 |
| , MD | Emergency Medicine | Maitland, FL | $330.00 | 1 |
| , M.D | Emergency Medicine | New Britain, CT | $73.92 | 4 |
| , DO | Emergency Medicine | Meriden, CT | $66.33 | 3 |
| , M.D | Emergency Medicine | New Britain, CT | $64.79 | 3 |
| , PA - C | Physician Assistant | Meriden, CT | $62.63 | 3 |
| , PA-C | Physician Assistant | New Haven, CT | $61.96 | 3 |
| , MD | Emergency Medicine | Springfield, IL | $59.00 | 3 |
| , MD | Emergency Medicine | Manchester, CT | $54.56 | 3 |
| , DO | Internal Medicine | Houston, TX | $54.30 | 3 |
| , PHYSICIAN ASSISTANT | Physician Assistant | Victoria, TX | $52.10 | 3 |
| , D.O | Emergency Medicine | Pittsburgh, PA | $49.28 | 2 |
| , FNP-C | Family | Scottsdale, AZ | $47.39 | 1 |
| , MD | Emergency Medicine | Newark, NJ | $45.62 | 2 |
| , PA | Physician Assistant | Southington, CT | $45.36 | 2 |
| , FNP-BC | Family | Baton Rouge, LA | $42.91 | 2 |
| , P.A | Physician Assistant | Meriden, CT | $42.77 | 2 |
Manufacturing Companies
- Purdue Pharma L.P. $1.7M
Product Information
- Type Drug
- Total Payments $1.7M
- Total Doctors 318
- Transactions 393
About NALMEFENE HYDROCHLORIDE
NALMEFENE HYDROCHLORIDE is a drug associated with $1.7M in payments to 318 healthcare providers, recorded across 393 transactions in the CMS Open Payments database. The primary manufacturer is Purdue Pharma L.P..
Payment data is available from 2022 to 2024. In 2024, $581,909 was paid across 280 transactions to 232 doctors.
The most common payment nature for NALMEFENE HYDROCHLORIDE is "Unspecified" ($1.6M, 97.1% of total).
NALMEFENE HYDROCHLORIDE is associated with 5 research studies, including "A Two-Part Study to Characterize the Pharmacokinetics of Nalmefene Hydrochloride and to Assess the Time Course of Reversal and Breakthrough of Opioid Agonist Effects Following Naloxone and Nalmefene Administration" ($919,395).